Annual Net Income
-$101.17 M
-$7.30 M-7.78%
December 31, 2023
Summary
- As of February 12, 2025, XFOR annual net profit is -$101.17 million, with the most recent change of -$7.30 million (-7.78%) on December 31, 2023.
- During the last 3 years, XFOR annual net income has fallen by -$39.04 million (-62.83%).
- XFOR annual net income is now -665.37% below its all-time high of -$13.22 million, reached on December 31, 2015.
Performance
XFOR Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$36.70 M
-$127.53 M-140.40%
September 30, 2024
Summary
- As of February 12, 2025, XFOR quarterly net profit is -$36.70 million, with the most recent change of -$127.53 million (-140.40%) on September 30, 2024.
- Over the past year, XFOR quarterly net income has dropped by -$127.53 million (-140.40%).
- XFOR quarterly net income is now -140.40% below its all-time high of $90.83 million, reached on June 30, 2024.
Performance
XFOR Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$16.76 M
-$34.39 M-195.05%
September 30, 2024
Summary
- As of February 12, 2025, XFOR TTM net profit is -$16.76 million, with the most recent change of -$34.39 million (-195.05%) on September 30, 2024.
- Over the past year, XFOR TTM net income has dropped by -$34.39 million (-195.05%).
- XFOR TTM net income is now -195.05% below its all-time high of $17.63 million, reached on June 30, 2024.
Performance
XFOR TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
XFOR Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.8% | -140.4% | -195.1% |
| 3 y3 years | -62.8% | -140.4% | -195.1% |
| 5 y5 years | -203.9% | -107.2% | +68.3% |
XFOR Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -14.1% | at low | -140.4% | +34.1% | -195.1% | +87.2% |
| 5 y | 5-year | -91.6% | at low | -140.4% | +34.1% | -195.1% | +87.2% |
| alltime | all time | -665.4% | at low | -140.4% | +34.1% | -195.1% | +87.2% |
X4 Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$36.70 M(-140.4%) | -$16.76 M(-195.0%) |
| Jun 2024 | - | $90.83 M(-275.5%) | $17.63 M(-113.7%) |
| Mar 2024 | - | -$51.77 M(+170.6%) | -$128.91 M(+27.4%) |
| Dec 2023 | -$101.17 M(+7.8%) | -$19.13 M(+729.9%) | -$101.17 M(-9.0%) |
| Sep 2023 | - | -$2.31 M(-95.9%) | -$111.14 M(-14.8%) |
| Jun 2023 | - | -$55.71 M(+131.9%) | -$130.42 M(+36.0%) |
| Mar 2023 | - | -$24.02 M(-17.5%) | -$95.92 M(+2.2%) |
| Dec 2022 | -$93.87 M(+5.8%) | -$29.10 M(+34.8%) | -$93.87 M(-1.2%) |
| Sep 2022 | - | -$21.59 M(+1.8%) | -$94.97 M(+1.5%) |
| Jun 2022 | - | -$21.21 M(-3.4%) | -$93.56 M(+1.7%) |
| Mar 2022 | - | -$21.96 M(-27.3%) | -$91.98 M(+3.7%) |
| Dec 2021 | -$88.70 M(+42.8%) | -$30.21 M(+49.7%) | -$88.70 M(+15.4%) |
| Sep 2021 | - | -$20.18 M(+2.7%) | -$76.89 M(+3.7%) |
| Jun 2021 | - | -$19.64 M(+5.2%) | -$74.16 M(+6.5%) |
| Mar 2021 | - | -$18.68 M(+1.5%) | -$69.67 M(+12.1%) |
| Dec 2020 | -$62.13 M | -$18.40 M(+5.5%) | -$62.13 M(+13.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$17.45 M(+15.2%) | -$54.57 M(-0.5%) |
| Jun 2020 | - | -$15.14 M(+36.0%) | -$54.83 M(+3.3%) |
| Mar 2020 | - | -$11.14 M(+2.8%) | -$53.07 M(+0.5%) |
| Dec 2019 | -$52.81 M(+58.7%) | -$10.84 M(-38.8%) | -$52.81 M(+27.0%) |
| Sep 2019 | - | -$17.71 M(+32.4%) | -$41.59 M(+19.6%) |
| Jun 2019 | - | -$13.38 M(+23.1%) | -$34.78 M(+3.7%) |
| Mar 2019 | - | -$10.87 M(-2976.5%) | -$33.53 M(+0.7%) |
| Dec 2018 | -$33.28 M(-1.7%) | $378.00 K(-103.5%) | -$33.28 M(-25.8%) |
| Sep 2018 | - | -$10.90 M(-10.2%) | -$44.85 M(-1.5%) |
| Jun 2018 | - | -$12.13 M(+14.1%) | -$45.55 M(+16.4%) |
| Mar 2018 | - | -$10.63 M(-5.0%) | -$39.12 M(+15.5%) |
| Dec 2017 | -$33.88 M(+47.5%) | -$11.19 M(-3.6%) | -$33.88 M(+20.9%) |
| Sep 2017 | - | -$11.60 M(+103.3%) | -$28.01 M(+70.7%) |
| Jun 2017 | - | -$5.71 M(+5.9%) | -$16.41 M(+53.3%) |
| Mar 2017 | - | -$5.38 M(+1.2%) | -$10.71 M(+101.2%) |
| Dec 2016 | -$22.98 M(+73.8%) | -$5.32 M | -$5.32 M |
| Dec 2015 | -$13.22 M | - | - |
FAQ
- What is X4 Pharmaceuticals annual net profit?
- What is the all time high annual net income for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals annual net income year-on-year change?
- What is X4 Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals quarterly net income year-on-year change?
- What is X4 Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals TTM net income year-on-year change?
What is X4 Pharmaceuticals annual net profit?
The current annual net income of XFOR is -$101.17 M
What is the all time high annual net income for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high annual net profit is -$13.22 M
What is X4 Pharmaceuticals annual net income year-on-year change?
Over the past year, XFOR annual net profit has changed by -$7.30 M (-7.78%)
What is X4 Pharmaceuticals quarterly net profit?
The current quarterly net income of XFOR is -$36.70 M
What is the all time high quarterly net income for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high quarterly net profit is $90.83 M
What is X4 Pharmaceuticals quarterly net income year-on-year change?
Over the past year, XFOR quarterly net profit has changed by -$127.53 M (-140.40%)
What is X4 Pharmaceuticals TTM net profit?
The current TTM net income of XFOR is -$16.76 M
What is the all time high TTM net income for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high TTM net profit is $17.63 M
What is X4 Pharmaceuticals TTM net income year-on-year change?
Over the past year, XFOR TTM net profit has changed by -$34.39 M (-195.05%)